Search Results

Education Full Text (H.W. Wilson)

Record details

Education Full Text (H.W. Wilson)

Record details

Applied Science & Technology Full Text (H.W. Wilson)

Record details

Comparison of the Efficacy of Ezetimibe Combination Therapy and High-Intensity Statin Monotherapy in Type 2 Diabetes.

• Authors : Park SY; Department of Endocrinology and Metabolism, Kyung Hee University Hospital, Seoul 02447, Republic of Korea.; Department of Endocrinology & Metabolism, Kyung Hee University School of Medicine, Seoul 02453, Republic of Korea.

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/blood

• Source: The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2024 Jun 17; Vol. 109 (7), pp. 1883-1890.Publisher: Oxford University Press Country of Publication: United States NLM ID: 0375362 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Impact of statin adherence and interruption within 6 months after ST-segment elevation myocardial infarction (STEMI): Results from the real-world regional registry FAST-STEMI.

• Authors : Giacobbe F; Division of Cardiology, Cardiovascular and Thoracic Department, Città della Salute e della Scienza, Turin, Italy; Department of Medical Sciences, University of Turin, Italy.

Subjects: ST Elevation Myocardial Infarction*/ST Elevation Myocardial Infarction*/ST Elevation Myocardial Infarction*/drug therapy ; ST Elevation Myocardial Infarction*/ST Elevation Myocardial Infarction*/ST Elevation Myocardial Infarction*/mortality ; Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/administration & dosage

• Source: International journal of cardiology [Int J Cardiol] 2024 Jun 15; Vol. 405, pp. 131933. Date of Electronic Publication: 2024 Mar 02.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8200291 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Statin use is associated with a lower risk of all-cause death in patients with breast cancer treated with anthracycline containing regimens: a global federated health database analysis.

• Authors : Bucci T; Liverpool Centre of Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart and Chest Hospital, Liverpool, UK. .; Department of Clinical Internal, Anesthesiologic and Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy. .

Subjects: Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/drug therapy ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/mortality ; Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use

• Source: Clinical and experimental medicine [Clin Exp Med] 2024 Jun 12; Vol. 24 (1), pp. 124. Date of Electronic Publication: 2024 Jun 12.Publisher: Springer-Verlag Italia Country of Publication: Italy NLM ID: 100973405 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Letter by Andreotti et al Regarding Article, "Inflammation and Cholesterol as Predictors of Cardiovascular Events Among 13 970 Contemporary High-Risk Patients With Statin Intolerance".

• Authors : Andreotti F; Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy (F.A., F.B.).; CardioThoracic Department, Catholic University Medical School, Rome, Italy (F.A., F.B.).

Subjects: Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/adverse effects ; Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use ; Cardiovascular Diseases*

• Source: Circulation [Circulation] 2024 Jun 11; Vol. 149 (24), pp. e1312. Date of Electronic Publication: 2024 Jun 10.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0147763 Publication Model: Print-Electronic Cited Medium:

Record details

Hypercholesterolaemia treated with inclisiran.

• Authors : Todorovac N; Afdeling for Hjertesygdomme, Sygehus Sønderjylland - Aabenraa.; Hansen MS

Subjects: Hyperlipoproteinemia Type II*/Hyperlipoproteinemia Type II*/Hyperlipoproteinemia Type II*/drug therapy ; PCSK9 Inhibitors* ; Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use

• Source: Ugeskrift for laeger [Ugeskr Laeger] 2024 Jun 10; Vol. 186 (24). Date of Electronic Publication: 2024 Jun 10.Publisher: Den Alm Danske Laegerforening Country of Publication: Denmark NLM ID: 0141730 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Statins Do Not Significantly Affect Oxidative Nitrosative Stress Biomarkers in the PREVENT Randomized Clinical Trial.

• Authors : Makhlin I; Division of Hematology and Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.; Demissei BG

Subjects: Oxidative Stress*/Oxidative Stress*/Oxidative Stress*/drug effects ; Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/pharmacology ; Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use

• Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Jun 03; Vol. 30 (11), pp. 2370-2376.Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265

Record details

Adherence to Current Dyslipidemia Guideline in Patients Utilizing Statins According to Risk Groups and Gender Differences: The AIZANOI Study.

• Authors : Şen T; Department of Cardiology, Faculty of Medicine, Kütahya Health Sciences University, Kütahya, Türkiye.; Dinç Asarcıklı L

Subjects: Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use ; Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/administration & dosage ; Guideline Adherence*/Guideline Adherence*/Guideline Adherence*/statistics & numerical data

• Source: Anatolian journal of cardiology [Anatol J Cardiol] 2024 Jun; Vol. 28 (6), pp. 273-282.Publisher: KARE publishing Country of Publication: Turkey NLM ID: 101652981 Publication Model: Print Cited Medium: Internet ISSN: 2149-2271

Record details